MARKET

VIR

VIR

Vir Biotechnology, Inc.
NASDAQ
5.94
-0.09
-1.49%
After Hours: 5.94 0 0.00% 18:56 01/02 EST
OPEN
6.03
PREV CLOSE
6.03
HIGH
6.10
LOW
5.84
VOLUME
1.22M
TURNOVER
--
52 WEEK HIGH
14.45
52 WEEK LOW
4.155
MARKET CAP
826.40M
P/E (TTM)
-1.6408
1D
5D
1M
3M
1Y
5Y
1D
3 ‘Strong Buy’ Stocks to Buy Now,12/30/2025, According to Top Analysts
TipRanks · 12/30/2025 14:30
Vir Biotechnology Price Target Maintained With a $15.00/Share by HC Wainwright & Co.
Dow Jones · 12/30/2025 13:43
HC Wainwright & Co. Reiterates Buy on Vir Biotechnology, Maintains $15 Price Target
Benzinga · 12/30/2025 13:33
Vir Biotechnology: Norgine Partnership Extends Cash Runway and De‑Risks HDV Franchise, Supporting Buy Rating and $15 Target
TipRanks · 12/30/2025 11:15
Weekly Report: what happened at VIR last week (1222-1226)?
Weekly Report · 12/29/2025 10:25
Weekly Report: what happened at VIR last week (1215-1219)?
Weekly Report · 12/22/2025 10:25
Analysts Are Bullish on Top Healthcare Stocks: Neurocrine (NBIX), Vir Biotechnology (VIR)
TipRanks · 12/17/2025 12:40
Vir Biotechnology: Strong HDV Performance and Strategic Partnership Drive Buy Rating
TipRanks · 12/17/2025 11:05
More
About VIR
Vir Biotechnology, Inc. is a clinical-stage biopharmaceutical company focused on powering the immune system to transform lives by discovering and developing medicines for serious infectious diseases and cancer. Its clinical-stage portfolio includes infectious disease programs for chronic hepatitis delta and chronic hepatitis B infections and multiple dual-masked T-cell engagers across validated targets in solid tumor indications. It also has a preclinical portfolio of programs across a range of infectious diseases and oncologic malignancies. Tobevibart is an investigational neutralizing monoclonal antibody (mAb) that has been engineered for immune engagement and targets a conserved region on the hepatitis B surface antigen (HBsAg). Elebsiran is an investigational HBV-targeted small interfering RNA (siRNA) that reduces HBsAg. Its pipeline includes VIR-5818, VIR-5500, VIR-5525, and HIV Cure. It also has rights to the PRO-XTEN masking platform for oncology and infectious disease.

Webull offers Vir Biotechnology Inc stock information, including NASDAQ: VIR real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VIR stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VIR stock methods without spending real money on the virtual paper trading platform.